Iain Ross - 18 Dec 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
Interim PEO, Director
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Issuer symbol
SLN
Transactions as of
18 Dec 2025
Net transactions value
$0
Form type
4
Filing time
22 Dec 2025, 18:04:27 UTC
Previous filing
06 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ross Iain Interim PEO, Director C/O SILENCE THERAPEUTICS PLC, 12 HAMMERSMITH GROVE, LONDON, UNITED KINGDOM /s/ Rhonda Hellums, Attorney-in-Fact 22 Dec 2025 0001307218

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN Employee Share Option (Right to Buy) Award $0 +900,000 $0.000000 900,000 18 Dec 2025 Ordinary Shares 900,000 $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in equal monthly installments over a one-year period measured from one month following December 18, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.